SI1255535T1 - Farmacevtski sestavek s kontroliranim sproscanjem, ki vsebuje tramadol hidroklorid - Google Patents

Farmacevtski sestavek s kontroliranim sproscanjem, ki vsebuje tramadol hidroklorid

Info

Publication number
SI1255535T1
SI1255535T1 SI200030873T SI200030873T SI1255535T1 SI 1255535 T1 SI1255535 T1 SI 1255535T1 SI 200030873 T SI200030873 T SI 200030873T SI 200030873 T SI200030873 T SI 200030873T SI 1255535 T1 SI1255535 T1 SI 1255535T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
controlled release
composition containing
release pharmaceutical
tramadol hydrochloride
Prior art date
Application number
SI200030873T
Other languages
English (en)
Slovenian (sl)
Inventor
L Uboslav Razus
Helena Sedlarov
Ivan Varga
Ondrej Gattnar
Marisn Zemanek
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Publication of SI1255535T1 publication Critical patent/SI1255535T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200030873T 1999-12-28 2000-12-20 Farmacevtski sestavek s kontroliranim sproscanjem, ki vsebuje tramadol hidroklorid SI1255535T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
EP00987947A EP1255535B1 (fr) 1999-12-28 2000-12-20 Composition pharmaceutique a liberation regulee contenant du chlorhydrate de tramadol et son procede de preparation
PCT/SK2000/000027 WO2001047497A2 (fr) 1999-12-28 2000-12-20 Composition pharmaceutique a liberation regulee contenant du chlorhydrate de tramadol et son procede de preparation

Publications (1)

Publication Number Publication Date
SI1255535T1 true SI1255535T1 (sl) 2006-10-31

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030873T SI1255535T1 (sl) 1999-12-28 2000-12-20 Farmacevtski sestavek s kontroliranim sproscanjem, ki vsebuje tramadol hidroklorid

Country Status (25)

Country Link
US (1) US20030175343A1 (fr)
EP (1) EP1255535B1 (fr)
JP (1) JP2003518486A (fr)
AT (1) ATE324103T1 (fr)
AU (1) AU2421601A (fr)
BG (1) BG65713B1 (fr)
CA (1) CA2397942C (fr)
CY (1) CY1106127T1 (fr)
CZ (1) CZ297394B6 (fr)
DE (1) DE60027601T2 (fr)
DK (1) DK1255535T3 (fr)
EA (1) EA006438B1 (fr)
EE (1) EE05231B1 (fr)
ES (1) ES2266018T3 (fr)
GE (1) GEP20053532B (fr)
HU (1) HUP0203842A3 (fr)
LT (1) LT5033B (fr)
LV (1) LV12917B (fr)
PL (1) PL208096B1 (fr)
PT (1) PT1255535E (fr)
SI (1) SI1255535T1 (fr)
SK (1) SK285128B6 (fr)
TW (1) TWI221419B (fr)
UA (1) UA76411C2 (fr)
WO (1) WO2001047497A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
CA2529604C (fr) * 2003-07-11 2012-05-08 Novartis Ag Compositions pharmaceutiques a dosage oral comprenant un agent d'apport sous forme micronisee
JP4926245B2 (ja) * 2006-06-09 2012-05-09 イノフォス インコーポレーテッド 透明飲料用のカルシウム強化物質
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
EP0654263B1 (fr) 1993-11-23 2002-01-23 Euro-Celtique S.A. Procédé pour la préparation d'une composition pharmaceutique à libération prolongée
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
PL357680A1 (en) 2004-07-26
EA200200720A1 (ru) 2003-02-27
JP2003518486A (ja) 2003-06-10
EA006438B1 (ru) 2005-12-29
CZ297394B6 (cs) 2006-12-13
CZ20022371A3 (cs) 2002-10-16
US20030175343A1 (en) 2003-09-18
BG65713B1 (bg) 2009-08-31
WO2001047497A2 (fr) 2001-07-05
EP1255535A2 (fr) 2002-11-13
TWI221419B (en) 2004-10-01
UA76411C2 (en) 2006-08-15
LT5033B (lt) 2003-07-25
BG106952A (en) 2003-03-31
EE05231B1 (et) 2009-12-15
SK285128B6 (sk) 2006-07-07
WO2001047497A3 (fr) 2002-09-12
CA2397942C (fr) 2008-07-15
CY1106127T1 (el) 2011-06-08
EP1255535B1 (fr) 2006-04-26
CA2397942A1 (fr) 2001-07-05
ES2266018T3 (es) 2007-03-01
EE200200368A (et) 2003-10-15
ATE324103T1 (de) 2006-05-15
LT2002078A (en) 2003-03-25
GEP20053532B (en) 2005-05-25
PT1255535E (pt) 2006-09-29
AU2421601A (en) 2001-07-09
LV12917B (en) 2003-02-20
DK1255535T3 (da) 2006-08-28
DE60027601D1 (de) 2006-06-01
HUP0203842A2 (hu) 2003-05-28
SK186899A3 (en) 2001-07-10
HUP0203842A3 (en) 2004-06-28
PL208096B1 (pl) 2011-03-31
DE60027601T2 (de) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2001032596A8 (fr) Composes d'acide carboxylique phenoxy et compositions utilisees afin de diffuser des agents actifs
CY1106127T1 (el) Φαρμακευτικη συσταση ελεγχομενης αποδεσμευσης που πepιεχει υδροχλωρικη τραμαδολη
ZA965609B (en) Controlled release formulations for poorly soluble drugs
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
YU76503A (sh) Farmaceutski aktivni estri uridina
MD872F1 (en) Pharmaceutical effervescent composition and preparation on the basis of it, method for preparation preparing
HUP0204513A3 (en) Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO1999047172A3 (fr) Compositions pharmaceutiques orales a prendre sans liquides et contenant des composes d'inclusion
WO2002053097A3 (fr) Compositions pharmaceutiques d'un inhibiteur de la pompe a protons non gastro-resistant avec une combinaison de sel de carbonate et de sel de bicarbonate
WO2001022969A3 (fr) Preparation d'agoniste de la vasopressine et procede de preparation
ES2172172T3 (es) Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion.
EP1153611A3 (fr) Composition pharmaceutique pour le traitement de la fibrose
WO2006064321A3 (fr) Compositions a liberation commandee de sodium de divalproex
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
CA2572498A1 (fr) Formulations de gelule a liberation biphasee